Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Early determination of renal allograft survival: a correlation between cytotoxic antibodies in recipient sera, renal pathology, and response to antirejection therapy.

Early determination of renal allograft survival: a correlation between cytotoxic antibodies in recipient sera, renal pathology, and response to antirejection therapy. Transplant Proc. 1984 Dec; 16(6):1588-90.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.